Karen Dillinger
Executive Director, Drug Safety at BioCryst Pharmaceuticals, Inc. - Durham, North Carolina, US
Karen Dillinger's Colleagues at BioCryst Pharmaceuticals, Inc.
Karen Dillinger's Contact Details
(919) 859-1302
Raleigh-Durham-Chapel Hill Area
BioCryst Pharmaceuticals, Inc.
Karen Dillinger's Company Details
BioCryst Pharmaceuticals is a global biotechnology company with a deep commitment to improving the lives of people living with hereditary angioedema (HAE) and other rare diseases. We leverage our expertise in structure-guided drug design to develop first-in-class or best-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases. We are a commercial-stage biotech company with US headquarters in Durham, North Carolina. Our European headquarters is in Dublin, Ireland, and our Discovery Center of Excellence is rooted in Birmingham, Alabama, with many other regional offices around the world. As world leaders in structure-guided drug design, we draw on the strengths and expertise of all our colleagues—from those of us in the field or behind the scenes in our labs, to others based in home offices and around the globe. To view our LinkedIn community guidelines, please visit bit.ly/BCRXGuidelines.